[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2020-2026

June 2020 | 99 pages | ID: G59C659F7821EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing ammonia from the bloodstream.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Urea Cycle Disorders (UCD) Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Urea Cycle Disorders (UCD) Treatment industry.
Based on our recent survey, we have several different scenarios about the Urea Cycle Disorders (UCD) Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Urea Cycle Disorders (UCD) Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Urea Cycle Disorders (UCD) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Urea Cycle Disorders (UCD) Treatment market in terms of revenue.
Players, stakeholders, and other participants in the global Urea Cycle Disorders (UCD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Urea Cycle Disorders (UCD) Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Urea Cycle Disorders (UCD) Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Urea Cycle Disorders (UCD) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Urea Cycle Disorders (UCD) Treatment market.
The following players are covered in this report:
  • Horizon Therapeutics
  • Eurocept BV
  • Recordati Rare Diseases Inc.
  • Synlogic
  • ...
Urea Cycle Disorders (UCD) Treatment Breakdown Data by Type
  • Amino Acid Formulas
  • Phenylbutyrate
  • Sodium Benzoate
  • Others
Urea Cycle Disorders (UCD) Treatment Breakdown Data by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Urea Cycle Disorders (UCD) Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Urea Cycle Disorders (UCD) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Amino Acid Formulas
  1.4.3 Phenylbutyrate
  1.4.4 Sodium Benzoate
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Urea Cycle Disorders (UCD) Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Urea Cycle Disorders (UCD) Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Urea Cycle Disorders (UCD) Treatment Industry
    1.6.1.1 Urea Cycle Disorders (UCD) Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Urea Cycle Disorders (UCD) Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Urea Cycle Disorders (UCD) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Urea Cycle Disorders (UCD) Treatment Market Perspective (2015-2026)
2.2 Urea Cycle Disorders (UCD) Treatment Growth Trends by Regions
  2.2.1 Urea Cycle Disorders (UCD) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Urea Cycle Disorders (UCD) Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Urea Cycle Disorders (UCD) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Urea Cycle Disorders (UCD) Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Urea Cycle Disorders (UCD) Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Urea Cycle Disorders (UCD) Treatment Players by Market Size
  3.1.1 Global Top Urea Cycle Disorders (UCD) Treatment Players by Revenue (2015-2020)
  3.1.2 Global Urea Cycle Disorders (UCD) Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Urea Cycle Disorders (UCD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Urea Cycle Disorders (UCD) Treatment Market Concentration Ratio
  3.2.1 Global Urea Cycle Disorders (UCD) Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Urea Cycle Disorders (UCD) Treatment Revenue in 2019
3.3 Urea Cycle Disorders (UCD) Treatment Key Players Head office and Area Served
3.4 Key Players Urea Cycle Disorders (UCD) Treatment Product Solution and Service
3.5 Date of Enter into Urea Cycle Disorders (UCD) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Urea Cycle Disorders (UCD) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Urea Cycle Disorders (UCD) Treatment Forecasted Market Size by Type (2021-2026)

5 UREA CYCLE DISORDERS (UCD) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020)
5.2 Global Urea Cycle Disorders (UCD) Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Urea Cycle Disorders (UCD) Treatment Market Size (2015-2020)
6.2 Urea Cycle Disorders (UCD) Treatment Key Players in North America (2019-2020)
6.3 North America Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020)
6.4 North America Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Urea Cycle Disorders (UCD) Treatment Market Size (2015-2020)
7.2 Urea Cycle Disorders (UCD) Treatment Key Players in Europe (2019-2020)
7.3 Europe Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020)
7.4 Europe Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Urea Cycle Disorders (UCD) Treatment Market Size (2015-2020)
8.2 Urea Cycle Disorders (UCD) Treatment Key Players in China (2019-2020)
8.3 China Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020)
8.4 China Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Urea Cycle Disorders (UCD) Treatment Market Size (2015-2020)
9.2 Urea Cycle Disorders (UCD) Treatment Key Players in Japan (2019-2020)
9.3 Japan Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020)
9.4 Japan Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Urea Cycle Disorders (UCD) Treatment Market Size (2015-2020)
10.2 Urea Cycle Disorders (UCD) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Urea Cycle Disorders (UCD) Treatment Market Size (2015-2020)
11.2 Urea Cycle Disorders (UCD) Treatment Key Players in India (2019-2020)
11.3 India Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020)
11.4 India Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Urea Cycle Disorders (UCD) Treatment Market Size (2015-2020)
12.2 Urea Cycle Disorders (UCD) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Horizon Therapeutics
  13.1.1 Horizon Therapeutics Company Details
  13.1.2 Horizon Therapeutics Business Overview and Its Total Revenue
  13.1.3 Horizon Therapeutics Urea Cycle Disorders (UCD) Treatment Introduction
  13.1.4 Horizon Therapeutics Revenue in Urea Cycle Disorders (UCD) Treatment Business (2015-2020))
  13.1.5 Horizon Therapeutics Recent Development
13.2 Eurocept BV
  13.2.1 Eurocept BV Company Details
  13.2.2 Eurocept BV Business Overview and Its Total Revenue
  13.2.3 Eurocept BV Urea Cycle Disorders (UCD) Treatment Introduction
  13.2.4 Eurocept BV Revenue in Urea Cycle Disorders (UCD) Treatment Business (2015-2020)
  13.2.5 Eurocept BV Recent Development
13.3 Recordati Rare Diseases Inc.
  13.3.1 Recordati Rare Diseases Inc. Company Details
  13.3.2 Recordati Rare Diseases Inc. Business Overview and Its Total Revenue
  13.3.3 Recordati Rare Diseases Inc. Urea Cycle Disorders (UCD) Treatment Introduction
  13.3.4 Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders (UCD) Treatment Business (2015-2020)
  13.3.5 Recordati Rare Diseases Inc. Recent Development
13.4 Synlogic
  13.4.1 Synlogic Company Details
  13.4.2 Synlogic Business Overview and Its Total Revenue
  13.4.3 Synlogic Urea Cycle Disorders (UCD) Treatment Introduction
  13.4.4 Synlogic Revenue in Urea Cycle Disorders (UCD) Treatment Business (2015-2020)
  13.4.5 Synlogic Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Urea Cycle Disorders (UCD) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Urea Cycle Disorders (UCD) Treatment Revenue
Table 3. Ranking of Global Top Urea Cycle Disorders (UCD) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Urea Cycle Disorders (UCD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Amino Acid Formulas
Table 6. Key Players of Phenylbutyrate
Table 7. Key Players of Sodium Benzoate
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Urea Cycle Disorders (UCD) Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Urea Cycle Disorders (UCD) Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Urea Cycle Disorders (UCD) Treatment Players to Combat Covid-19 Impact
Table 14. Global Urea Cycle Disorders (UCD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Urea Cycle Disorders (UCD) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Urea Cycle Disorders (UCD) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Urea Cycle Disorders (UCD) Treatment Market Share by Regions (2015-2020)
Table 18. Global Urea Cycle Disorders (UCD) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Urea Cycle Disorders (UCD) Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Urea Cycle Disorders (UCD) Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Urea Cycle Disorders (UCD) Treatment Players
Table 25. Global Urea Cycle Disorders (UCD) Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Urea Cycle Disorders (UCD) Treatment Market Share by Players (2015-2020)
Table 27. Global Top Urea Cycle Disorders (UCD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urea Cycle Disorders (UCD) Treatment as of 2019)
Table 28. Global Urea Cycle Disorders (UCD) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Urea Cycle Disorders (UCD) Treatment Product Solution and Service
Table 31. Date of Enter into Urea Cycle Disorders (UCD) Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Urea Cycle Disorders (UCD) Treatment Market Size Share by Type (2015-2020)
Table 35. Global Urea Cycle Disorders (UCD) Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Urea Cycle Disorders (UCD) Treatment Market Size Share by Application (2015-2020)
Table 37. Global Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Urea Cycle Disorders (UCD) Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Urea Cycle Disorders (UCD) Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Urea Cycle Disorders (UCD) Treatment Market Share (2019-2020)
Table 41. North America Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Urea Cycle Disorders (UCD) Treatment Market Share by Type (2015-2020)
Table 43. North America Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Urea Cycle Disorders (UCD) Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Urea Cycle Disorders (UCD) Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Urea Cycle Disorders (UCD) Treatment Market Share (2019-2020)
Table 47. Europe Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Urea Cycle Disorders (UCD) Treatment Market Share by Type (2015-2020)
Table 49. Europe Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Urea Cycle Disorders (UCD) Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Urea Cycle Disorders (UCD) Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Urea Cycle Disorders (UCD) Treatment Market Share (2019-2020)
Table 53. China Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Urea Cycle Disorders (UCD) Treatment Market Share by Type (2015-2020)
Table 55. China Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Urea Cycle Disorders (UCD) Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Urea Cycle Disorders (UCD) Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Urea Cycle Disorders (UCD) Treatment Market Share (2019-2020)
Table 59. Japan Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Urea Cycle Disorders (UCD) Treatment Market Share by Type (2015-2020)
Table 61. Japan Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Urea Cycle Disorders (UCD) Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Urea Cycle Disorders (UCD) Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Urea Cycle Disorders (UCD) Treatment Market Share (2019-2020)
Table 65. Southeast Asia Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Urea Cycle Disorders (UCD) Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Urea Cycle Disorders (UCD) Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Urea Cycle Disorders (UCD) Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Urea Cycle Disorders (UCD) Treatment Market Share (2019-2020)
Table 71. India Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Urea Cycle Disorders (UCD) Treatment Market Share by Type (2015-2020)
Table 73. India Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Urea Cycle Disorders (UCD) Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Urea Cycle Disorders (UCD) Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Urea Cycle Disorders (UCD) Treatment Market Share (2019-2020)
Table 77. Central & South America Urea Cycle Disorders (UCD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Urea Cycle Disorders (UCD) Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Urea Cycle Disorders (UCD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Urea Cycle Disorders (UCD) Treatment Market Share by Application (2015-2020)
Table 81. Horizon Therapeutics Company Details
Table 82. Horizon Therapeutics Business Overview
Table 83. Horizon Therapeutics Product
Table 84. Horizon Therapeutics Revenue in Urea Cycle Disorders (UCD) Treatment Business (2015-2020) (Million US$)
Table 85. Horizon Therapeutics Recent Development
Table 86. Eurocept BV Company Details
Table 87. Eurocept BV Business Overview
Table 88. Eurocept BV Product
Table 89. Eurocept BV Revenue in Urea Cycle Disorders (UCD) Treatment Business (2015-2020) (Million US$)
Table 90. Eurocept BV Recent Development
Table 91. Recordati Rare Diseases Inc. Company Details
Table 92. Recordati Rare Diseases Inc. Business Overview
Table 93. Recordati Rare Diseases Inc. Product
Table 94. Recordati Rare Diseases Inc. Revenue in Urea Cycle Disorders (UCD) Treatment Business (2015-2020) (Million US$)
Table 95. Recordati Rare Diseases Inc. Recent Development
Table 96. Synlogic Company Details
Table 97. Synlogic Business Overview
Table 98. Synlogic Product
Table 99. Synlogic Revenue in Urea Cycle Disorders (UCD) Treatment Business (2015-2020) (Million US$)
Table 100. Synlogic Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Urea Cycle Disorders (UCD) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Amino Acid Formulas Features
Figure 3. Phenylbutyrate Features
Figure 4. Sodium Benzoate Features
Figure 5. Others Features
Figure 6. Global Urea Cycle Disorders (UCD) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Urea Cycle Disorders (UCD) Treatment Report Years Considered
Figure 11. Global Urea Cycle Disorders (UCD) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Urea Cycle Disorders (UCD) Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Urea Cycle Disorders (UCD) Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Urea Cycle Disorders (UCD) Treatment Market Share by Players in 2019
Figure 16. Global Top Urea Cycle Disorders (UCD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urea Cycle Disorders (UCD) Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Urea Cycle Disorders (UCD) Treatment Revenue in 2019
Figure 18. North America Urea Cycle Disorders (UCD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Urea Cycle Disorders (UCD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Urea Cycle Disorders (UCD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Urea Cycle Disorders (UCD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Urea Cycle Disorders (UCD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Urea Cycle Disorders (UCD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Urea Cycle Disorders (UCD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Horizon Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Horizon Therapeutics Revenue Growth Rate in Urea Cycle Disorders (UCD) Treatment Business (2015-2020)
Figure 27. Eurocept BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eurocept BV Revenue Growth Rate in Urea Cycle Disorders (UCD) Treatment Business (2015-2020)
Figure 29. Recordati Rare Diseases Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Recordati Rare Diseases Inc. Revenue Growth Rate in Urea Cycle Disorders (UCD) Treatment Business (2015-2020)
Figure 31. Synlogic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Synlogic Revenue Growth Rate in Urea Cycle Disorders (UCD) Treatment Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed


More Publications